Trial Profile
Variance analysis of hepatic functional reserve in TACE and TACE combined with Sorafenib for HCC
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 21 Jun 2012
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Antineoplastics
- Indications Liver cancer
- Focus Adverse reactions
- 21 Jun 2012 New trial record